Tue, May 07, 2019, 3:00pm
Location:
NCRC, Building 16, 266C
Allison Kurian, MD, MSc
Associate Professor Of Medicine (Oncology) And Of Health Research And Policy
The Stanford University Medical Center
Abstract: Next-generation sequencing technology has made genetic testing for cancer risk more comprehensive, faster and cheaper than ever before. Yet questions remain about the impact of widespread genetic testing on cancer patients and their relatives, in terms of treatment decision-making and quality of life. I will discuss recent progress and ongoing research in this area.